{"id":9742,"date":"2026-04-01T10:08:12","date_gmt":"2026-04-01T02:08:12","guid":{"rendered":"https:\/\/regask.com\/?p=9742"},"modified":"2026-04-01T10:08:12","modified_gmt":"2026-04-01T02:08:12","slug":"brasiliens-anvisa-aktualisiert-informationen-zu-covid-19-impfstoffstammen-risikoarmen-medikamenten-und-inhaltsstoffen","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/","title":{"rendered":"Brasilianische ANVISA aktualisiert COVID-19-Impfstoffst\u00e4mme, Niedrigrisiko-Impfstoffe\u2026"},"content":{"rendered":"<p>An <strong>24. M\u00e4rz 2026,<\/strong> Die <strong>Brasilianische Nationale Gesundheits\u00fcberwachungsbeh\u00f6rde (ANVISA)<\/strong> k\u00fcndigte eine Reihe regulatorischer Aktualisierungen an, die Auswirkungen haben auf<strong> Zusammensetzung des COVID-19-Impfstoffs, Meldeverfahren f\u00fcr Arzneimittel mit geringem Risiko, Inhaltsstoffe von Nahrungserg\u00e4nzungsmitteln und Beschr\u00e4nkungen f\u00fcr Kosmetikprodukte.<\/strong> Die \u00c4nderungen gelten f\u00fcr <strong>Pharmahersteller, Hersteller von Nahrungserg\u00e4nzungsmitteln und Kosmetikunternehmen<\/strong> operativ in Brasilien.<\/p>\n<div class=\"row\"  id=\"row-1936737619\">\n\n\t<div id=\"col-1695923769\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-1280043330\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1280043330 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Details zum Update<\/h2>\n\t<div id=\"gap-396609766\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-396609766 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Das Update f\u00fchrt zu mehr Flexibilit\u00e4t in\u00a0<\/span><b><span data-contrast=\"auto\">Zusammensetzung des COVID-19-Impfstoffs<\/span><\/b><span data-contrast=\"auto\">, wodurch Impfstoffe entweder die\u00a0<\/span><b><span data-contrast=\"auto\">LP.8.1<\/span><\/b><span data-contrast=\"auto\">\u00a0oder\u00a0<\/span><b><span data-contrast=\"auto\">JN.1-Virusst\u00e4mme<\/span><\/b><span data-contrast=\"auto\">, Die endg\u00fcltige Auswahl unterliegt dem Ermessen des Gesundheitsministeriums.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Parallel dazu hat ANVISA den Anwendungsbereich erweitert\u00a0<\/span><b><span data-contrast=\"auto\">Arzneimittel mit geringem Risiko, die f\u00fcr eine vereinfachte Meldung vor der Vermarktung in Frage kommen<\/span><\/b><span data-contrast=\"auto\">, jetzt einschlie\u00dflich\u00a0<\/span><b><span data-contrast=\"auto\">Povidon-Iod, Paracetamol, Simeticon und Bismutsubsalicylat<\/span><\/b><span data-contrast=\"auto\">, wodurch die regulatorischen Zulassungsverfahren f\u00fcr diese Produkte vereinfacht werden.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Die Beh\u00f6rde hat au\u00dferdem neue genehmigt\u00a0<\/span><b><span data-contrast=\"auto\">Inhaltsstoffe von Nahrungserg\u00e4nzungsmitteln<\/span><\/b><span data-contrast=\"auto\">, einschlie\u00dflich\u00a0<\/span><b><span data-contrast=\"auto\">Baru-Nuss\u00f6l<\/span><\/b><span data-contrast=\"auto\">,\u00a0<\/span><b><span data-contrast=\"auto\">Mikroalgen\u00f6l mit DHA (<\/span><\/b><b><i><span data-contrast=\"auto\">Schizochytrium<\/span><\/i><\/b><b><span data-contrast=\"auto\">\u00a0sp.)<\/span><\/b><span data-contrast=\"auto\">,\u00a0<\/span><b><span data-contrast=\"auto\">lyophilisiertes A\u00e7a\u00ed-Konzentrat<\/span><\/b><span data-contrast=\"auto\">,\u00a0<\/span><b><span data-contrast=\"auto\">Bifidobacterium animalis subsp. Lactis<\/span><\/b><span data-contrast=\"auto\">, Und\u00a0<\/span><b><span data-contrast=\"auto\">Streptococcus salivarius K12<\/span><\/b><span data-contrast=\"auto\">. Diese Inhaltsstoffe unterliegen\u00a0<\/span><b><span data-contrast=\"auto\">festgelegte Nutzungsgrenzen und Kennzeichnungsvorschriften<\/span><\/b><span data-contrast=\"auto\">, wodurch die Einhaltungspflichten verst\u00e4rkt werden.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Dar\u00fcber hinaus hat ANVISA die\u00a0<\/span><b><span data-contrast=\"auto\">Verbot von Nagelprodukten, die Diphenyl(2,4,6-trimethylbenzoyl)phosphinoxid (TPO) und N,N-Dimethyl-p-toluidin (DMPT) enthalten<\/span><\/b><span data-contrast=\"auto\">. Die Beschr\u00e4nkung bleibt ungeachtet etwaiger anh\u00e4ngiger Rechtsmittel in Kraft, was die strikte Durchsetzung best\u00e4tigt.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1695923769 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1973230690\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Datum des Inkrafttretens<\/h2>\n\t<div id=\"gap-1013914953\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1013914953 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW194959746 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW194959746 BCX0\">Die regulatorischen Aktualisierungen waren\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW194959746 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW194959746 BCX0\">angek\u00fcndigt am 24. M\u00e4rz 2026<\/span><\/span><span class=\"TextRun SCXW194959746 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW194959746 BCX0\">.<\/span><\/span><span class=\"EOP SCXW194959746 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1973230690 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-2042499762\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Warum es wichtig ist<\/h2>\n\t<div id=\"gap-721170505\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-721170505 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Diese Aktualisierungen verbessern<strong> regulatorische Klarheit<\/strong> durch die Definition zul\u00e4ssiger Impfstoffst\u00e4mme und zugelassener Inhaltsstoffe, w\u00e4hrend gleichzeitig unterst\u00fctzt wird<strong> digitale und verfahrenstechnische Effizienz<\/strong> durch vereinfachte Meldeverfahren f\u00fcr Arzneimittel mit geringem Risiko. Gleichzeitig wird durch die fortgesetzte Durchsetzung der Kosmetikbeschr\u00e4nkungen sichergestellt <strong>einheitliche Compliance-Standards<\/strong> mit minimalem zus\u00e4tzlichem regulatorischen Aufwand f\u00fcr konforme Produkte.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-2042499762 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-222450291\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Wen das betrifft<\/h2>\n\t<div id=\"gap-197155810\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-197155810 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">Dieses Update ist relevant f\u00fcr<strong>\u00a0<\/strong><\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">Teams f\u00fcr regulatorische Angelegenheiten, Qualit\u00e4tssicherung, Forschung und Entwicklung sowie Compliance<\/span><\/span><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">,<\/span><\/span><\/strong><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\"> sowie <\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">IT- und Digitalisierungsteams<\/span><\/span><\/strong><span class=\"TextRun SCXW220643823 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW220643823 BCX0\">\u00a0verantwortlich f\u00fcr die Verwaltung regulatorischer Arbeitsabl\u00e4ufe und Produktdaten im gesamten Portfolio von Arzneimitteln, Nahrungserg\u00e4nzungsmitteln und Kosmetika.<\/span><\/span><span class=\"EOP SCXW220643823 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-222450291 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1484568839\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>N\u00e4chste Schritte<\/h2>\n\t<div id=\"gap-802515904\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-802515904 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Unternehmen sollten\u00a0<\/span><b><span data-contrast=\"auto\">aktuelle Produktportfolios bewerten<\/span><\/b><span data-contrast=\"auto\">\u00a0im Hinblick auf die aktualisierten Anforderungen, einschlie\u00dflich der Optionen f\u00fcr die Impfstoffzusammensetzung, der Berechtigung zur Meldung von Arzneimitteln mit geringem Risiko, der zugelassenen Inhaltsstoffe von Nahrungserg\u00e4nzungsmitteln und der Beschr\u00e4nkungen f\u00fcr kosmetische Substanzen, sollten die Beteiligten sich abstimmen.\u00a0<\/span><b><span data-contrast=\"auto\">funktions\u00fcbergreifende \u00dcberpr\u00fcfungen<\/span><\/b><span data-contrast=\"auto\">\u00a0Aktualisierung der beh\u00f6rdlichen Unterlagen, der Kennzeichnungspraxis und der Lieferkettenkontrollen, um die fortlaufende Einhaltung der ANVISA-Vorschriften zu gew\u00e4hrleisten.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Da regulatorische Aktualisierungen in verschiedenen Produktkategorien immer h\u00e4ufiger und komplexer werden, k\u00f6nnen Unternehmen von zentralisierten Informationen und Automatisierung profitieren, um den Ver\u00e4nderungen einen Schritt voraus zu sein.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/de\/\">RegASK<\/a>\u00a0ist eine f\u00fchrende agentenbasierte KI-Plattform f\u00fcr regulatorische Intelligenz und Workflow-Orchestrierung<\/span><\/b><span data-contrast=\"auto\">\u00a0Das System bef\u00e4higt globale Organisationen in stark regulierten Branchen, darunter Konsumg\u00fcter und Biowissenschaften, sich proaktiv in komplexen regulatorischen Umfeldern zu bewegen. Durch die Kombination von fortschrittlicher agentenbasierter KI mit Expertenwissen,\u00a0<a href=\"http:\/\/regask.com\/de\/\">RegASK<\/a>\u00a0liefert zeitnahe, vorausschauende und umsetzbare Erkenntnisse sowie eine durchg\u00e4ngige Automatisierung, optimiert Compliance-Prozesse, mindert Risiken und beschleunigt den Marktzugang in mehr als 160 L\u00e4ndern.\u00a0<\/span><b><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/de\/\">Mehr erfahren<\/a> oder <a href=\"https:\/\/regask.com\/de\/demo-buchen\/\">Jetzt Demo buchen.<\/a><\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1484568839 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-341175282\">\n\n\t<div id=\"col-1482743226\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>FAQs<\/h3>\n\t<div id=\"gap-486166651\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-486166651 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW85757934 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85757934 BCX0\">Welche COVID-19-St\u00e4mme gibt es?\u00a0<\/span><span class=\"NormalTextRun SCXW85757934 BCX0\">gestattet<\/span><span class=\"NormalTextRun SCXW85757934 BCX0\">\u00a0gem\u00e4\u00df den aktualisierten ANVISA-Richtlinien?<\/span><\/span><span class=\"EOP SCXW85757934 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-703167342\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-703167342 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW132553472 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW132553472 BCX0\">COVID-19-Impfstoffe k\u00f6nnen entweder Folgendes umfassen:\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW132553472 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW132553472 BCX0\">LP.8.1- oder JN.1-Virusst\u00e4mme<\/span><\/span><\/strong><span class=\"TextRun SCXW132553472 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW132553472 BCX0\"><strong>,<\/strong> mit dem letzten\u00a0<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">Auswahl<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">bestimmt<\/span><span class=\"NormalTextRun SCXW132553472 BCX0\">\u00a0vom Gesundheitsministerium.<\/span><\/span><span class=\"EOP SCXW132553472 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1482743226 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1339553633\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW177685408 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW177685408 BCX0\">Welche Arzneimittel sind in Brasilien f\u00fcr ein vereinfachtes Meldeverfahren qualifiziert?<\/span><\/span><span class=\"EOP SCXW177685408 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-134518141\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-134518141 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><strong><span class=\"TextRun MacChromeBold SCXW62415161 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW62415161 BCX0\">Povidon-Iod, Paracetamol, Simeticon und Bismutsubsalicylat<\/span><\/span><\/strong><span class=\"TextRun SCXW62415161 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW62415161 BCX0\">\u00a0Sie sind nun vor ihrer Markteinf\u00fchrung als Arzneimittel mit geringem Risiko f\u00fcr eine vereinfachte Meldung qualifiziert.<\/span><\/span><span class=\"EOP SCXW62415161 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1339553633 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-568711398\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW147526865 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW147526865 BCX0\">Welche neuen Inhaltsstoffe sind f\u00fcr Nahrungserg\u00e4nzungsmittel zugelassen?<\/span><\/span><span class=\"EOP SCXW147526865 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-599675735\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-599675735 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Zugelassene Inhaltsstoffe umfassen\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Baru-Nuss\u00f6l<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">,\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Mikroalgen\u00f6l mit DHA (<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SpellingErrorV2Themed SCXW152755442 BCX0\">Schizochytrium<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">\u00a0sp.)<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">,\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">lyophilisiertes A\u00e7a\u00ed-Konzentrat<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">,\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Bifidobakterium\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW152755442 BCX0\">animalis<\/span><span class=\"NormalTextRun SCXW152755442 BCX0\">\u00a0subsp. lactis<\/span><\/span><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">, Und\u00a0<\/span><\/span><span class=\"TextRun MacChromeBold SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\">Streptococcus salivarius K12<\/span><\/span><\/strong><span class=\"TextRun SCXW152755442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW152755442 BCX0\"><strong>,<\/strong> Vorbehaltlich der Nutzungsbeschr\u00e4nkungen und Kennzeichnungsvorschriften.<\/span><\/span><span class=\"EOP SCXW152755442 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-568711398 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1429137282\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW204239453 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW204239453 BCX0\">Wie kann\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW204239453 BCX0\">RegASK<\/span><span class=\"NormalTextRun SCXW204239453 BCX0\">\u00a0Hilfe bei Aktualisierungen zur TITCK-Konformit\u00e4t?<\/span><\/span><span class=\"EOP SCXW204239453 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-630345712\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-630345712 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW193127493 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/de\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW193127493 BCX0\">RegASK<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW193127493 BCX0\">\u00a0hilft Organisationen\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW193127493 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW193127493 BCX0\">Regulatorische \u00c4nderungen in Echtzeit verfolgen, Produktauswirkungen bewerten und Compliance-Workflows optimieren.<\/span><\/span><\/strong><span class=\"TextRun SCXW193127493 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW193127493 BCX0\"><strong>,<\/strong> erm\u00f6glicht eine schnellere Anpassung an\u00a0<\/span><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW193127493 BCX0\">Aktualisierungen<\/span><span class=\"NormalTextRun SCXW193127493 BCX0\">\u00a0wie beispielsweise \u00c4nderungen der Impfstoffzusammensetzung, Zulassungen von Inhaltsstoffen und Produktbeschr\u00e4nkungen in Brasilien.<\/span><\/span><span class=\"EOP SCXW193127493 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1429137282 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On March 24, 2026, the Brazilian National Health Surveillance Agency (ANVISA) announced a set of regulatory updates impacting COVID-19 vaccine composition, low-risk medicines notification procedures, dietary supplement ingredients, and cosmetic product restrictions. The changes apply to pharmaceutical manufacturers, dietary supplement producers, and cosmetic companies operating in Brazil.<\/p>","protected":false},"author":43,"featured_media":9743,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,512,35],"tags":[],"class_list":["post-9742","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-brazil-regulations","category-pharma-biotech-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Brazil ANVISA Updates COVID-19 Vaccine Strains and Rules<\/title>\n<meta name=\"description\" content=\"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/brasiliens-anvisa-aktualisiert-informationen-zu-covid-19-impfstoffstammen-risikoarmen-medikamenten-und-inhaltsstoffen\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Risk Medicines, and Ingredient Rules\" \/>\n<meta property=\"og:description\" content=\"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/brasiliens-anvisa-aktualisiert-informationen-zu-covid-19-impfstoffstammen-risikoarmen-medikamenten-und-inhaltsstoffen\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-01T02:08:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Ris&hellip;\",\"datePublished\":\"2026-04-01T02:08:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\"},\"wordCount\":749,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"articleSection\":[\"Regulatory News\",\"Brazil\",\"Pharma and Biotech\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\",\"name\":\"Brazil ANVISA Updates COVID-19 Vaccine Strains and Rules\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"datePublished\":\"2026-04-01T02:08:12+00:00\",\"description\":\"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png\",\"width\":800,\"height\":600,\"caption\":\"Brazil Anvisa Updates Covid 19 Vaccine Strains Low Risk Medicines And Ingredient Rules\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Die brasilianische Visumbeh\u00f6rde ANVISA aktualisiert die COVID-19-Impfstoffst\u00e4mme und -Bestimmungen.","description":"Informieren Sie sich \u00fcber die neuesten ANVISA-Updates zu COVID-19-Impfstoffst\u00e4mmen und neuen Regeln f\u00fcr risikoarme Arzneimittel und Inhaltsstoffe.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/brasiliens-anvisa-aktualisiert-informationen-zu-covid-19-impfstoffstammen-risikoarmen-medikamenten-und-inhaltsstoffen\/","og_locale":"de_DE","og_type":"article","og_title":"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Risk Medicines, and Ingredient Rules","og_description":"Explore the latest Brazil ANVISA updates on COVID-19 vaccine strains and new rules for low-risk medicines and ingredients.","og_url":"https:\/\/regask.com\/de\/brasiliens-anvisa-aktualisiert-informationen-zu-covid-19-impfstoffstammen-risikoarmen-medikamenten-und-inhaltsstoffen\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-04-01T02:08:12+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#article","isPartOf":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Ris&hellip;","datePublished":"2026-04-01T02:08:12+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/"},"wordCount":749,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","articleSection":["Regulatory News","Brazil","Pharma and Biotech"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/","url":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/","name":"Die brasilianische Visumbeh\u00f6rde ANVISA aktualisiert die COVID-19-Impfstoffst\u00e4mme und -Bestimmungen.","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","datePublished":"2026-04-01T02:08:12+00:00","description":"Informieren Sie sich \u00fcber die neuesten ANVISA-Updates zu COVID-19-Impfstoffst\u00e4mmen und neuen Regeln f\u00fcr risikoarme Arzneimittel und Inhaltsstoffe.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/04\/brazil-anvisa-updates-covid-19-vaccine-strains-low-risk-medicines-and-ingredient-rules.png","width":800,"height":600,"caption":"Brazil Anvisa Updates Covid 19 Vaccine Strains Low Risk Medicines And Ingredient Rules"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/9742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=9742"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/9742\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/9743"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=9742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=9742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=9742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}